Correction to: Paraneoplastic Erythropoiesis in Patients with Ovarian Sertoli Leydig Cell Tumors: Retrospective Study from Tertiary Care Institute

Correction to: Indian Journal of Surgical Oncology

https://doi.org/10.1007/s13193-022-01585-9

The published version of this paper contained some errors. The images were not included.

The appropriate images are shown below (Images 1, 2, 3, and 4).

Image 1.

Specimen of unilateral salphingo-oophorectomy. Well encapsulated ovarian tumour measuring 6 × 3.8 × 3.4 cm. The cut surface has a homogenous yellowish area with no necrotic foci

Image 2.

A case of Leydig cell tumour: A Circumscribed tumour with peripheral normal ovarian stroma (H&EX40); B Sheets of tumour cells with eosinophilic to clear cytoplasm admixed with occasional Reinke crystalloids (arrowhead) (HXEX200); C PAS stain highlights Reinke crystalloids (arrow) (PASX200); D IHC with calretinin show cytoplasmic positivity (DABX200)

Image 3.

A case of ovarian steroid cell tumour: a Encapsulated specimen with cut surface show yellowish areas; b Sheets, lobules of tumour cells (H&EX100); c High power show round to polygonal cells with moderate to abundant clear to eosinophilic cytoplasm and bland oval nuclei (H&EX400): oil red O stain highlights these cells (inset); d IHC with inhibin show strong cytoplasmic positivity (DABX400)

Image 4.

A case of ovarian Sertoli-Leydig cell tumour: a Encapsulated tumour arranged in papillae (H&EX40) as well as in b Compact glands with a minimal stromal background composed of round to oval pleomorphic cells (H&EX100); c Focal clusters of Leydig cells in nests (H&EX200); d Immunohistochemistry (IHC) shows strong cytoplasmic positivity with cytokeratin (DABX100); e Calretinin (DABX200); f Estrogen receptor strong nuclear positivity (DABX200)

This is being corrected in this publication.